Contact Us
Encephalitis Treatment Global Market Report 2025
Global Encephalitis Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Encephalitis Treatment Global Market Report 2025

By Disease Type (Primary Encephalitis, Secondary Encephalitis), By Treatment (Antiviral Agents, Steroid Injections, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Other Treatments), By Route of Administration (Oral, Parenteral, Other Routes Of Administrations), By Diagnosis (Imaging Tests, Blood Tests, Biopsy, Other Diagnosis), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Encephalitis Treatment Market Overview

• Encephalitis Treatment market size has reached to $21.09 billion in 2024

• Expected to grow to $27.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Increasing Investment In Healthcare Infrastructure Boosts Encephalitis Treatment Market Growth

• Market Trend: Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Receptor Encephalitis

North America was the largest region in 2024.

What Is Covered Under Encephalitis Treatment Market?

Encephalitis treatment is the treatment of a medical condition characterized by inflammation of the brain, usually caused by a viral infection, a fungal infection, an autoimmune reaction, or certain medications. Encephalitis treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

The main disease type included in encephalitis treatment are primary encephalitis, secondary encephalitis. Primary encephalitis refers to an inflammation of the brain that originates directly within the brain rather than being caused by an infection elsewhere in the body. Primary encephalitis treatment includes antiviral medications, supportive care, and management of symptoms. The treatment types are antiviral agents, steroid injections, antibiotics, immunoglobulin therapy, plasmapheresis, and other treatment, that uses route of administration, such as oral, parenteral, and other routes of administrations. The diagnosis test types are imaging tests, Blood Tests, biopsy, and other diagnosis, with end users as hospitals, specialty clinics, and others.

Encephalitis Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Encephalitis Treatment Market Size 2025 And Growth Rate?

The encephalitis treatment market size has grown strongly in recent years. It will grow from $21.09 billion in 2024 to $22.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to high incidence of encephalitis, prevalence of viral or bacterial infection, growing government initiatives, rising demand for preventive encephalitis vaccines.

What Is The Encephalitis Treatment Market Growth Forecast?

The encephalitis treatment market size is expected to see strong growth in the next few years. It will grow to $27.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising healthcare expenditure, increase in the popularity of physical therapy, growing geriatric population, increasing awareness of encephalitis treatment. Major trends in the forecast period include advanced diagnostic tools, AI and ml in encephalitis diagnosis and treatment, development of personalized medicines, demand for preventive encephalitis vaccines, supportive cares.

The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of intravenous immunoglobulins (IVIG) and antiviral medications sourced from Austria and Belgium, thereby slowing acute treatment responses and elevating neurology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Encephalitis Treatment Market Segmented?

1) By Disease Type: Primary Encephalitis, Secondary Encephalitis

2) By Treatment: Antiviral Agents, Steroid Injections, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By Diagnosis: Imaging Tests, Blood Tests, Biopsy, Other Diagnosis

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Primary Encephalitis: Viral Encephalitis, Bacterial Encephalitis, Fungal Encephalitis, Parasitic Encephalitis

2) By Secondary Encephalitis: Post-Infectious Encephalitis, Autoimmune Encephalitis, Encephalitis Due To Systemic

What Is Driving The Encephalitis Treatment Market? Increasing Investment In Healthcare Infrastructure Boosts Encephalitis Treatment Market Growth

Rising investment in healthcare infrastructure is expected to propel the growth of the encephalitis treatment market going forward. Healthcare infrastructure refers to the facilities, resources and services that support the delivery of medical care to individuals and communities. These facilities consist of hospitals, clinics and medical laboratories equipped with modern technology and staffed by trained healthcare professionals. The healthcare infrastructure plays a critical role in treating encephalitis by providing access to specialized medical facilities, diagnostic tools and supportive care. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the US increased from 6,129 in 2021 to 6,093 in 2022. Therefore, the rising investment in healthcare infrastructure is driving the growth of the encephalitis treatment industry.

What Is Driving The Encephalitis Treatment Market? Increasing Neuroinvasive Disease Cases Fuel Growth In The Encephalitis Treatment Market

A rising number of neuroinvasive disease cases is expected to propel the growth of the encephalitis treatment market. Neuroinvasive disease refers to a medical condition in which a pathogen, such as a virus or bacteria, enters the nervous system and causes inflammation or damage to the nervous tissues. The escalating prevalence of neuroinvasive diseases drives demand for encephalitis and related treatments, prompting pharmaceutical companies and researchers to invest in developing new therapies and medications to meet the growing patient needs. For instance, in June 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of neuroinvasive La Crosse virus human disease cases reported in the month of September 2022 reached 8, compared to 6 in the month of July 2022. Moreover, total cases reported in Ohio accounted for 13, the largest of any other region of the USA. Therefore, a rising number of neuroinvasive disease cases will drive the growth of the encephalitis treatment industry.

Who Are The Major Players In The Global Encephalitis Treatment Market?

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.

What Are The Key Trends Of The Global Encephalitis Treatment Market? Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Receptor Encephalitis

Major companies operating in the encephalitis treatment market are focused on strategic investments to accelerate the development of innovative therapies, enhance their research and development capabilities, and expand clinical trials. For instance, in September 2023, Arialys Therapeutics, a US-based preclinical-stage company, secured $58 million in seed funding to advance its lead candidate, ART5803, designed to treat anti-NMDA receptor encephalitis (ANRE), a prevalent form of autoimmune encephalitis. The company plans to initiate clinical trials with healthy volunteers by late 2024, followed by testing in ANRE patients in early 2025. Arialys is focused on developing precision therapies that specifically target pathogenic antibodies impacting the central nervous system.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Encephalitis Treatment Market? Substipharm Expands Encephalitis Treatment Portfolio With Acquisition Of Imojev Vaccine From Sanofi

In November 2022, Substipharm, a France-based pharmaceutical company, acquired the IMOJEV Japanese encephalitis vaccine from Sanofi S.A. for an undisclosed amount. This acquisition enhances Substipharm's position in encephalitis treatment and is an ideal addition to the company's geographic expansion. Sanofi S.A. is a France-based pharmaceutical company specializing in manufacturing a wide range of medicines and vaccines, including the encephalitis vaccine.

Regional Outlook For The Global Encephalitis Treatment Market

North America was the largest region in the encephalitis treatment market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Encephalitis Treatment Market?

The encephalitis treatment market consists of revenues earned by entities by providing plasmapheresis, immunoglobulin therapy, computed tomography (CT scans), magnetic resonance imaging (MRI) and magnetoencephalography (MEG) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The encephalitis treatment market also includes sales of immunosuppressant drugs, antiseizure medicines and immunomodulators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Encephalitis Treatment Industry?

The encephalitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the encephalitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Encephalitis Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $22.17 billion
Revenue Forecast In 2034 $27.66 billion
Growth Rate CAGR of 5.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Disease Type: Primary Encephalitis, Secondary Encephalitis
2) By Treatment: Antiviral Agents, Steroid Injections, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By Diagnosis: Imaging Tests, Blood Tests, Biopsy, Other Diagnosis
5) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments: 1) By Primary Encephalitis: Viral Encephalitis, Bacterial Encephalitis, Fungal Encephalitis, Parasitic Encephalitis
2) By Secondary Encephalitis: Post-Infectious Encephalitis, Autoimmune Encephalitis, Encephalitis Due To Systemic
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Encephalitis Treatment Market Characteristics

3. Encephalitis Treatment Market Trends And Strategies

4. Encephalitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Encephalitis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Encephalitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Encephalitis Treatment Market Growth Rate Analysis

5.4. Global Encephalitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Encephalitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Encephalitis Treatment Total Addressable Market (TAM)

6. Encephalitis Treatment Market Segmentation

6.1. Global Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Primary Encephalitis

Secondary Encephalitis

6.2. Global Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiviral Agents

Steroid Injections

Antibiotics

Immunoglobulin Therapy

Plasmapheresis

Other Treatments

6.3. Global Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Routes Of Administrations

6.4. Global Encephalitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imaging Tests

Blood Tests

Biopsy

Other Diagnosis

6.5. Global Encephalitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

6.6. Global Encephalitis Treatment Market, Sub-Segmentation Of Primary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Encephalitis

Bacterial Encephalitis

Fungal Encephalitis

Parasitic Encephalitis

6.7. Global Encephalitis Treatment Market, Sub-Segmentation Of Secondary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Post-Infectious Encephalitis

Autoimmune Encephalitis

Encephalitis Due To Systemic

7. Encephalitis Treatment Market Regional And Country Analysis

7.1. Global Encephalitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Encephalitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Encephalitis Treatment Market

8.1. Asia-Pacific Encephalitis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Encephalitis Treatment Market

9.1. China Encephalitis Treatment Market Overview

9.2. China Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Encephalitis Treatment Market

10.1. India Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Encephalitis Treatment Market

11.1. Japan Encephalitis Treatment Market Overview

11.2. Japan Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Encephalitis Treatment Market

12.1. Australia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Encephalitis Treatment Market

13.1. Indonesia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Encephalitis Treatment Market

14.1. South Korea Encephalitis Treatment Market Overview

14.2. South Korea Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Encephalitis Treatment Market

15.1. Western Europe Encephalitis Treatment Market Overview

15.2. Western Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Encephalitis Treatment Market

16.1. UK Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Encephalitis Treatment Market

17.1. Germany Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Encephalitis Treatment Market

18.1. France Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Encephalitis Treatment Market

19.1. Italy Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Encephalitis Treatment Market

20.1. Spain Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Encephalitis Treatment Market

21.1. Eastern Europe Encephalitis Treatment Market Overview

21.2. Eastern Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Encephalitis Treatment Market

22.1. Russia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Encephalitis Treatment Market

23.1. North America Encephalitis Treatment Market Overview

23.2. North America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Encephalitis Treatment Market

24.1. USA Encephalitis Treatment Market Overview

24.2. USA Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Encephalitis Treatment Market

25.1. Canada Encephalitis Treatment Market Overview

25.2. Canada Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Encephalitis Treatment Market

26.1. South America Encephalitis Treatment Market Overview

26.2. South America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Encephalitis Treatment Market

27.1. Brazil Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Encephalitis Treatment Market

28.1. Middle East Encephalitis Treatment Market Overview

28.2. Middle East Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Encephalitis Treatment Market

29.1. Africa Encephalitis Treatment Market Overview

29.2. Africa Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Encephalitis Treatment Market Competitive Landscape And Company Profiles

30.1. Encephalitis Treatment Market Competitive Landscape

30.2. Encephalitis Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Encephalitis Treatment Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Novartis AG

31.3. Sanofi S.A.

31.4. Bristol Myers Squibb

31.5. Abbott Laboratories

31.6. GlaxoSmithKline plc

31.7. Takeda Pharmaceutical Company Limited

31.8. Eli Lilly and Company

31.9. Amgen Inc.

31.10. Teva Pharmaceutical Industries

31.11. Regeneron Pharmaceuticals

31.12. Aurobindo Pharma Limited

31.13. Hikma Pharmaceuticals plc

31.14. Vir Biotechnology

31.15. Torrent Pharmaceuticals Ltd.

32. Global Encephalitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Encephalitis Treatment Market

34. Recent Developments In The Encephalitis Treatment Market

35. Encephalitis Treatment Market High Potential Countries, Segments and Strategies

35.1 Encephalitis Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Encephalitis Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Encephalitis Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Encephalitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Encephalitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Encephalitis Treatment Market, Sub-Segmentation Of Primary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Encephalitis Treatment Market, Sub-Segmentation Of Secondary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Encephalitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Encephalitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: F. Hoffmann-La Roche Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance
  • Table 82: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Encephalitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Encephalitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Encephalitis Treatment Market, Sub-Segmentation Of Primary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Encephalitis Treatment Market, Sub-Segmentation Of Secondary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Encephalitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Encephalitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: F. Hoffmann-La Roche Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance

Frequently Asked Questions

Encephalitis treatment is the treatment of a medical condition characterized by inflammation of the brain, usually caused by a viral infection, a fungal infection, an autoimmune reaction, or certain medications. Encephalitis treatment is used to manage symptoms, slow down the progression of the disease and prevent complications. For further insights on this market, request a sample here

The market major growth driver - Increasing Investment In Healthcare Infrastructure Boosts Encephalitis Treatment Market Growth. For further insights on this market, request a sample here

The encephalitis treatment market size has grown strongly in recent years. It will grow from $21.09 billion in 2024 to $22.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to high incidence of encephalitis, prevalence of viral or bacterial infection, growing government initiatives, rising demand for preventive encephalitis vaccines. The encephalitis treatment market size is expected to see strong growth in the next few years. It will grow to " $27.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising healthcare expenditure, increase in the popularity of physical therapy, growing geriatric population, increasing awareness of encephalitis treatment. Major trends in the forecast period include advanced diagnostic tools, ai and ml in encephalitis diagnosis and treatment, development of personalized medicines, demand for preventive encephalitis vaccines, supportive cares. For further insights on this market, request a sample here

The encephalitis treatmentmarket covered in this report is segmented –
1) By Disease Type: Primary Encephalitis; Secondary Encephalitis
2) By Treatment: Antiviral Agents; Steroid Injections; Antibiotics; Immunoglobulin Therapy; Plasmapheresis; Other Treatments
3) By Route of Administration: Oral; Parenteral; Other Routes Of Administrations
4) By Diagnosis: Imaging Tests; Blood Tests; Biopsy; Other Diagnosis
5) By End-User: Hospitals; Specialty Clinics; Other End-Users Subsegments:
1) By Primary Encephalitis: Viral Encephalitis; Bacterial Encephalitis; Fungal Encephalitis; Parasitic Encephalitis
2) By Secondary Encephalitis: Post-Infectious Encephalitis; Autoimmune Encephalitis; Encephalitis Due To Systemic For further insights on this market,
request a sample here

North America was the largest region in the encephalitis treatment market in 2024. The regions covered in encephalitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.. For further insights on this market, request a sample here.

Major trends in this market include Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Receptor Encephalitis. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top